vs
Side-by-side financial comparison of SLM Corp (SLM) and Bio-Techne (TECH). Click either name above to swap in a different company.
SLM Corp is the larger business by last-quarter revenue ($560.0M vs $295.9M, roughly 1.9× Bio-Techne). SLM Corp runs the higher net margin — 55.0% vs 12.8%, a 42.2% gap on every dollar of revenue. Over the past eight quarters, SLM Corp's revenue compounded faster (22.7% CAGR vs 4.2%).
Nikon SLM Solutions AG, headquartered in Lübeck, Germany, is a manufacturer of 3D metal printers listed on the stock market and co-owner of the word mark SLM. The shares of SLM Solutions Group AG have been listed in Prime Standard of the Frankfurt Stock Exchange since May 9, 2014.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
SLM vs TECH — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $560.0M | $295.9M |
| Net Profit | $308.0M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | 69.6% | 18.4% |
| Net Margin | 55.0% | 12.8% |
| Revenue YoY | — | -6.4% |
| Net Profit YoY | 1.0% | 68.3% |
| EPS (diluted) | $1.54 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $560.0M | — | ||
| Q4 25 | $377.1M | $295.9M | ||
| Q3 25 | $373.0M | — | ||
| Q2 25 | $376.8M | $317.0M | ||
| Q1 25 | $375.0M | $316.2M | ||
| Q4 24 | $362.2M | $297.0M | ||
| Q3 24 | $359.4M | $289.5M | ||
| Q2 24 | $372.2M | $306.1M |
| Q1 26 | $308.0M | — | ||
| Q4 25 | $233.2M | $38.0M | ||
| Q3 25 | $135.8M | — | ||
| Q2 25 | $71.3M | $-17.7M | ||
| Q1 25 | $304.5M | $22.6M | ||
| Q4 24 | $111.6M | $34.9M | ||
| Q3 24 | $-45.2M | $33.6M | ||
| Q2 24 | $252.0M | $40.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% |
| Q1 26 | 69.6% | — | ||
| Q4 25 | 83.8% | 18.4% | ||
| Q3 25 | 49.8% | — | ||
| Q2 25 | 23.3% | -7.5% | ||
| Q1 25 | — | 12.2% | ||
| Q4 24 | 36.5% | 16.0% | ||
| Q3 24 | -16.6% | 13.8% | ||
| Q2 24 | 91.0% | 15.0% |
| Q1 26 | 55.0% | — | ||
| Q4 25 | 61.8% | 12.8% | ||
| Q3 25 | 36.4% | — | ||
| Q2 25 | 18.9% | -5.6% | ||
| Q1 25 | 81.2% | 7.1% | ||
| Q4 24 | 30.8% | 11.7% | ||
| Q3 24 | -12.6% | 11.6% | ||
| Q2 24 | 67.7% | 13.3% |
| Q1 26 | $1.54 | — | ||
| Q4 25 | $1.11 | $0.24 | ||
| Q3 25 | $0.63 | — | ||
| Q2 25 | $0.32 | $-0.11 | ||
| Q1 25 | $1.40 | $0.14 | ||
| Q4 24 | $0.53 | $0.22 | ||
| Q3 24 | $-0.23 | $0.21 | ||
| Q2 24 | $1.11 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.2B | $172.9M |
| Total DebtLower is stronger | $6.2B | $260.0M |
| Stockholders' EquityBook value | $2.4B | $2.0B |
| Total Assets | $29.4B | $2.5B |
| Debt / EquityLower = less leverage | 2.53× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $5.2B | — | ||
| Q4 25 | $4.2B | $172.9M | ||
| Q3 25 | $3.5B | — | ||
| Q2 25 | $4.1B | $162.2M | ||
| Q1 25 | $3.7B | $140.7M | ||
| Q4 24 | $4.7B | $177.5M | ||
| Q3 24 | $4.5B | $187.5M | ||
| Q2 24 | $5.3B | $152.9M |
| Q1 26 | $6.2B | — | ||
| Q4 25 | $5.4B | $260.0M | ||
| Q3 25 | $6.8B | — | ||
| Q2 25 | $6.4B | $346.0M | ||
| Q1 25 | $6.1B | $330.0M | ||
| Q4 24 | $6.4B | $300.0M | ||
| Q3 24 | $6.0B | $300.0M | ||
| Q2 24 | $5.4B | $319.0M |
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.5B | $2.0B | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.4B | $1.9B | ||
| Q1 25 | $2.4B | $2.0B | ||
| Q4 24 | $2.2B | $2.1B | ||
| Q3 24 | $2.1B | $2.1B | ||
| Q2 24 | $2.3B | $2.1B |
| Q1 26 | $29.4B | — | ||
| Q4 25 | $29.7B | $2.5B | ||
| Q3 25 | $29.6B | — | ||
| Q2 25 | $29.6B | $2.6B | ||
| Q1 25 | $28.9B | $2.6B | ||
| Q4 24 | $30.1B | $2.7B | ||
| Q3 24 | $30.0B | $2.7B | ||
| Q2 24 | $28.8B | $2.7B |
| Q1 26 | 2.53× | — | ||
| Q4 25 | 2.19× | 0.13× | ||
| Q3 25 | 2.92× | — | ||
| Q2 25 | 2.70× | 0.18× | ||
| Q1 25 | 2.56× | 0.16× | ||
| Q4 24 | 2.98× | 0.14× | ||
| Q3 24 | 2.83× | 0.14× | ||
| Q2 24 | 2.37× | 0.15× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SLM
| Net Interest Income | $375.0M | 67% |
| Noninterest Income | $185.0M | 33% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
